Anja Rakas

Mrs. Anja Rakas

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2025 in Molecules
Verified
Journal Article
Open access
PDF file
ARAnja Rakas
Anja Rakas
LPLeentje Persoons
Leentje Persoons
DDDirk Daelemans
Dirk Daelemans
Dajana Kučić GrgićDajana Kučić Grgić
Dajana Kučić Grgić
TKTatjana Gazivoda Kraljević
Tatjana Gazivoda Kraljević
This study describes the synthesis of O-alkylated benzaldehydes 1–8, Schiff bases 9–28, and benzoxazole derivatives 29–48 using microwave, ultrasound, and mechanochemical reactions, as well as reactions in deep eutectic solvents in excellent yields, and their antiproliferative and antibacterial activities. The in vitro evaluation of antiproliferative activity for the newly synthesised benzoxazole derivatives 29–48 against a diverse panel of human cancer cell lines, such as LN-229, Capan-1, HCT-116, NCI-H460, DND-41, HL-60, K-562, and Z-138 demonstrated that the majority of these benzoxazole derivatives displayed promising anticancer activity, particularly against non-small cell lung cancer (NSCLC) cells (NCI-H460). Notably, several derivatives showed enhanced activity compared to the included reference drug, etoposide. Considering the influence of substituents at position 5 of the benzoxazole ring and positions 3 and 4 of the phenyl ring on the antiproliferative activity, it is evident that derivatives 41–48 bearing a methoxy group at position 3 generally exhibit higher activity compared to compounds 29–40, which lack substitution at position 3. Furthermore, derivatives substituted at position 4 with a morpholine substituent, as well as those with an N,N-diethyl group, exhibited higher activity compared to other evaluated benzoxazole derivatives. The in vitro antibacterial evaluation against Gram-positive and Gram-negative bacteria revealed that benzoxazole derivative 47 exhibited notable activity, against the Gram-negative bacterium Pseudomonas aeruginosa (MIC = 0.25 μg/mL) and the Gram-positive bacterium Enterococcus faecalis (MIC = 0.5 μg/mL). The results point out that this class of benzoxazoles can be efficiently synthesized using eco-friendly methods and represent promising candidates for further design and optimization aimed at developing potent antiproliferative agents.

30 April 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
ISIvana Sokol
Ivana Sokol
ARAnja Rakas
Anja Rakas
DGDajana Kučić Grgić
Dajana Kučić Grgić
LPLeentje Persoons
Leentje Persoons
DDDirk Daelemans
Dirk Daelemans
TKTatjana Gazivoda Kraljević
Tatjana Gazivoda Kraljević
This paper describes ultrasound synthesis, structural characterization and biological activity of new derivatives of 2-arylbenzimidazole 12–27 and 1,2,3-triazole derivatives of 2-arylbenzimidazole 28–33. The tautomeric structures of the prepared target compounds were confirmed by 1H- and 13C-NMR spectroscopy as well as by two-dimensional NOESY, HSQC and HMBC methods. The synthesized compounds underwent in vitro antiproliferative assays, revealing that compound 23 exhibited the highest potency against chronic myeloid leukemia cells (K-562, IC50 = 2.0 μM) and non-Hodgkin's lymphoma cells (Z-138, IC50 = 2.0 μM). Compound 23 was further evaluated for cytotoxicity on normal peripheral blood mononuclear cells (PBMC), and its mechanism of action was investigated. The antibacterial properties of the synthesized compounds were assessed against both Gram-positive and Gram-negative bacterial strains. Derivatives 15–17 exhibited significant selective antibacterial activity against the Gram-positive bacterium Enterococcus faecalis (MIC = 0.25–1 μg mL−1). Additionally, among the 1,2,3-triazole derivatives of 2-arylbenzimidazole, compounds 28 and 30 demonstrated strong selective activity against Enterococcus faecalis (MIC = 0.25 μg mL−1).

1 March 2026 in Current Medicinal Chemistry
Verified
Journal Article
Open access
RORobert Ostrički
Robert Ostrički
ARAnja Rakas
Anja Rakas
VRVesna Rastija
Vesna Rastija
LPLeentje Persoons
Leentje Persoons
DDDirk Daelemans
Dirk Daelemans
TKTatjana Gazivoda Kraljević
Tatjana Gazivoda Kraljević
Introduction: Benzoxazole is a privileged scaffold with diverse biological activities, and its hybridization with a 1,2,3-triazole ring can improve affinity and efficacy. This study aimed to synthesize novel 1,2,3-triazole derivatives of 2-aminobenzoxazole and 2-mercaptobenzoxazole, and to evaluate their antiproliferative activity, predicted pharmacokinetic properties, and molecular interactions with kinase targets. Methods: 1,2,3-triazole derivatives of 2-aminobenzoxazole 3−15 and 2-mercaptobenzoxazole 18−32 were synthesized via cyclization, propargylation, and copper-catalyzed click reaction. Antiproliferative activity was evaluated against human cancer cell lines: LN-229, Capan-1, HCT-116, NCI-H460, DND-41, HL-60, K-562, and Z-138. The ADME properties of 1,2,3-triazole-benzoxazole hybrids were evaluated using the SwissADME tool. The most active compounds were assessed for Human Gastrointestinal Absorption (HGA) and Blood-Brain Barrier (BBB) permeability using the Egan model. Molecular docking was performed on serine/threonine kinase TAO2 and tyrosine kinase c-Src. Results: A series of novel 1,2,3-triazole derivatives of 2-amino 3-15 and 2-mercaptobenzoxazole 18-32 were synthesized via click chemistry. Coumarin-containing compounds 3 and 29 showed the most pronounced antiproliferative activity across all tested cell lines. Both demonstrated high predicted HGA and low likelihood of crossing the BBB. Compound 3 exhibited the highest binding affinity for TAO2, while compound 29 showed strong interaction with c-Src. Discussion: The results highlight the favorable influence of coumarin substitution on antiproliferative activity, with computational ADME and docking data supporting the observed in vitro efficacy. Conclusion: This study outlines a viable method for the synthesis of novel 1,2,3-triazole derivatives of 2-aminobenzoxazole and 2-mercaptobenzoxazole. Compounds 3 and 29 demonstrate promising antiproliferative activity and pharmacokinetic potential, supporting their further development as anticancer candidates.

25 October 2026 in Water
Verified
Journal Article
Open access
PDF file
LVLuka Večenaj
Luka Večenaj
DLDora Lastovčić
Dora Lastovčić
KMKristina Bule Možar
Kristina Bule Možar
LZLeonarda Zovko
Leonarda Zovko
ARAnja Rakas
Anja Rakas
MCMatija Cvetnić
Matija Cvetnić
The increasing presence of SARS-CoV-2 antiviral substances (SASs) in wastewater threatens aquatic ecosystems, making it necessary to better understand their removal efficiency during photooxidative treatment. The aim of this study was to evaluate UV-C/H2O2 and UV-C/S2O82− processes for treating thirteen SASs (atazanavir, daclatasvir, darunavir, emtricitabine, favipiravir, lopinavir, nirmatrelvir, oseltamivir, remdesivir, ribavirin, ritonavir, sofosbuvir, and umifenovir). The influence of pH and oxidant concentration on antivirals’ degradation was studied through full factorial plan and response surface modeling. It was established that degradation by both photooxidative processes obeys pseudo-first-order kinetic regime. Degradation kinetics of SASs is highly dependent on both process parameters, [SAS]:[OX], and pH, respectively, except for UMF in the UV-C/H2O2 process where the process is dependent only on pH. Regarding the reaction kinetics, in most cases degradation kinetics in UV-C/S2O82− processes are several times faster in comparison to UV-C/H2O2 process.